Skip to main content
Raphael Pollock, MD, General Surgery, Columbus, OH, The OSUCCC - James

RaphaelE.PollockMDPhD, FACS

General Surgery Columbus, OH

Surgical Oncology (Other than Breast)

Director of The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute

Dr. Pollock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pollock's full profile

Already have an account?

Summary

  • Raphael E. Pollock, MD, PhD, Dr. Pollock joined the faculty of the University of Texas MD Anderson Cancer Center in 1984 upon completion of fellowship training at that institution. In 1993 Dr. Pollock began service as Chairman of the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, a position that he held until 2010. In 1996, service as Head of the Division of Surgery at the University of Texas MD Anderson Cancer Center was begun, a position entailing supervisory relationships with all seven surgical specialty departments at that institution. In 2013 Dr. Pollock was recruited to The Ohio State University as Professor and Director of the Division of Surgical Oncology and Chief of Surgical Services at the James Comprehensive Cancer Center. This was followed by appointment in 2015 as Surgeon in Chief, the James Comprehensive Cancer Center and Surgeon in Chief, The Ohio State University Health System. In 2017, Dr. Pollock was appointed to his current position as Professor and Director, The Ohio State University Comprehensive Cancer Center.
    Dr. Pollock’s clinical and laboratory research work focuses on soft tissue sarcoma, a rare tumor system of connective tissue origin.
  • Pollock Lab | OSUCCC - James

    The Sarcoma Research Laboratory is a translational investigative environment focusing on soft tissue sarcoma and related malignancies led by Raphael Pollock, MD

    Raphael Pollock | The Ohio State University Wexner Medical Center

    Director, The Ohio State University Comprehensive Cancer Center Raphael Pollock is an internationally renowned cancer surgeon with more than three decades of ex

    Raphael Pollock, MD, PhD- Sarcoma Cancer Treatment

    Dr. Pollock has a lifetime dedication to patient care & research in soft tissue sarcoma. Learn of his association with Sarcoma Foundation of America.

    Raphael E. Pollock, MD, PhD

    The James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA Dr. Pollock joined the faculty of the University of Texas MD Anderson Cancer C

    Dr. Raphael E Pollock - Cancer Researcher at OSUCCC - James

    Raphael Pollock, MD, PhD, is a practicing surgical oncologist and director of The Ohio State University Comprehensive Cancer Center (OSUCCC). He is also a membe

    Dr. Raphael E Pollock

    Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2016, 2017 Named to the Castle Connolly list of "America's Top Doctors," 2004-

    Cancer care, treatment & research experts | OSUCCC - James

    Here is some information from The Ohio State University Comprehensive Cancer Center - (OSUCCC - James) I wanted to share with you.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonPh.D., 1990
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1982 - 1984
  • Rush University Medical Center
    Rush University Medical CenterResidency, Surgery, 1980 - 1982
  • University of Chicago
    University of ChicagoResidency, Surgery, 1977 - 1980
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineClass of 1977
  • Oberlin College
    Oberlin CollegeBA, History, High Honors, 1972

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2026
  • TX State Medical License
    TX State Medical License 1985 - 2015
  • IL State Medical License
    IL State Medical License 1978 - 1987
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2020
  • Daniel M. Miller Distinguished Lecturer University of Nebraska, 2014
  • Top Doctors:SE Texas Castle Connolly, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival  
    Alexander J Lazar, Joseph A Ludwig, Cynthia E Herzog, Raphael E Pollock, Clinical Cancer Research
  • Histone deacetylase inhibition for the treatment of epithelioid sarcoma; novel cross talk between epigenetic components  
    Song Y, Lopez G, Lam R, Ruder D, Creighton C, Bid HK, Bolshakov S, Zhang X, Lev D, Pollock RE, Mol Cancer Res, 1/1/2016
  • Contemporary approaches to sarcoma  
    Pollock RE, Kraybill WG, J Surg Onc, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Surgical stress generation of suppressor cells which impair natural killer cell cytotoxicity
    Pollock RE, Lotzova E, Stanford D, Romsdahl M, American Association for Cancer Research, Houston, TX, 1/1/1985
  • Soft tissue sarcomas of the shoulder: factors influencing local recurrence, distant metastases, and survival
    Meterissian SH, Reilly JA, Murphy A, Romsdahl MM, Pollock RE, Society Surgical Oncology, Houston, TX, 1/18/1994
  • Splenic natural killer cell cytotoxicity (NKCC) can be augmented in patients with leukemia
    Pollock RE, Savary C, Lotzova E, American Association for Cancer Research, Washington, DC, 1/24/1990
  • Join now to see all

Lectures

  • New surgical approaches to soft tissue sarcomas 
    Paris, France - 1/6./1997
  • Wild type p53 transfection inhibits soft tissue sarcoma growth and enhances chemosensitivity 
    Paris, France - 1/4./1997
  • International oncology education 
    Lyon, France - 1/20/1997
  • Join now to see all

Other

  • Mechanisms of Surgical Stress Impairment of Murine Natural Killer Cell Cytotoxicity 
    Pollock R, Ph.D. Dissertation

Press Mentions

  • Bridget Oppong Tapped as Deputy Director of Ohio State's Center for Cancer Health Equity
    Bridget Oppong Tapped as Deputy Director of Ohio State's Center for Cancer Health EquityNovember 30th, 2021
  • Ohio State Offering Additional COVID-19 Shot for Immunocompromised People
    Ohio State Offering Additional COVID-19 Shot for Immunocompromised PeopleAugust 17th, 2021
  • Doubling down: Pelotonia Plans to Increase Fundraising to $50 Million Annually by 2026
    Doubling down: Pelotonia Plans to Increase Fundraising to $50 Million Annually by 2026June 30th, 2021
  • Join now to see all

Grant Support

  • Soft Tissue Sarcoma--P53 And VEGF InductionNational Cancer Institute2000–2004
  • Training Of Academic Surgical OncologistsNational Cancer Institute1996–1999
  • Therapy And Biological Correlates Of Soft-Tissue SarcomaNational Cancer Institute1995–1998
  • NK Cell Genesis From Human Bone Marrow ProgenitorsNational Cancer Institute1993–1994
  • Surgical Stress Impairment Of Human NK Cell CytotoxicityNational Cancer Institute1990–1994
  • Natural Killer Cell--Toxicology Following SurgeryNational Cancer Institute1988
  • Chem Study Of Natl Killer Cell TOX Following Surg StressNational Cancer Institute1987
  • Physician-Investigator Development Award ProgramNational Cancer Institute1985–1986

Professional Memberships

Hospital Affiliations